Foghorn Therapeutics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Foghorn Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $10.21M.
- Foghorn Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $102.82M.
- Foghorn Therapeutics Inc. stock issued during period, value, new issues for fiscal 2024 was $102.82M.
- Foghorn Therapeutics Inc. stock issued during period, value, new issues for fiscal 2021 was $42.20M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $10.21M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $102.82M 10-K · filed 2026-03-11 | |
| 2024-06-30 | $102.82M 10-Q · filed 2025-11-05 | |
| 2021-12-31 | $42.20M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |